Japanese Pharmacopoeia (JP18) - Translation of Supplement II just Released.

US FDA CDER’s work to help develop a nitrosamines acceptable intake limit approach

China publishes guidelines in push to reform regulations by 2027

ndia’s CDSCO gives small manufacturers more time to comply with new GMP rules

FDA Proposes Framework to Advance Credibility of AI Models Used for Drug and Biological Product Submissions

Batch uniformity: FDA details testing approaches for continuous manufacturing

FDA issues final guidance on advance manufacturing technologies designation program

CDMO sector looks to recovery in 2025 amid positive macro, industry trends